Delivery Order SPE2DB22D9330-SPE2DB24FK8ML
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The order, valued at $21,729.24, has a completion date of February 2, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the SPE2DB program, which has a ceiling value of up to $4,999,999 and supports...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $126,753.90 firm fixed-price delivery order is for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. holds an Indefinite Delivery Vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, with the DLA valued at up to $4,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $50,490.00 firm fixed-price contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, with a period of performance through August 28, 2023. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical distributor based in Park Ridge, Illinois. The $90,538.50 firm fixed-price contract is for the delivery of BEYFORTUS 100 mg/mL syringes. The award has no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract 4600082013 under the DLA's SPE2DB program, valued up to $4,999,999 through 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,917.34 firm fixed-price delivery order is for BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product, under the DLA's Medical Supply Chain program. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $5,295.36 firm fixed-price delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a ceiling value of $5,295.36 and an ultimate completion date of March 11, 2024. This award is part of a larger indefinite delivery vehicle (IDV) contract #SPE2DB24D9134 between DMS Pharmaceutical Group...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $9,053.85 order is for BEYFORTUS 100 MG/ML SYRINGEML and is part of a larger, single-award indefinite delivery contract valued up to $4,999,999 through 2025. The contract enables DLA to issue delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of a variety of pharmaceutical items, including injectable medications, tablets, creams, and specialty drugs, to support the medical supply needs of U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $1,368.39 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,978.75 contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML and has a completion date of July 9, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of BEYFORTUS 100 MG/ML SYRINGE/ML. The contract has a ceiling value of $1,629.58 and is set to expire on December 8, 2023. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) with...